Ashland Global Hlds

Ashland, Inc. engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. It operates through the following segments: Life Sciences, Personal Care, Special Additives, and Intermediates. The company was founded in 1924 and is headquartered in Wilmington, DE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Ashland Global Hlds reports solid Q1 performance amidst regional challenges

Ashland Global Hlds' Q1 earnings call highlighted a mix of strong performance, challenges in certain regions, and opportunities for growth through strategic initiatives. The company's focus on enhancing shareholder value, addressing market uncertainties, and driving innovation positions it for future success.

Ashland Global Hlds faces Q2 challenges, eyes pharma growth

Ashland Global Hlds faced challenges in Q2 2023 from global uncertainties and destocking, impacting margins and earnings, while showing strength in the pharma and Life Sciences segments.
The company's strategic focus on M&A in growth areas and ending destocking actions in key segments present opportunities for revenue growth and value creation.
Despite challenges, Ashland's performance reflects resilience and strategic decision-making, with a positive outlook for cash flow improvement and long-term growth.
Investors should monitor the company's progress in addressing challenges, leveraging strengths, and capitalizing on opportunities to drive sustainable financial performance.

Ashland Global Hlds faces destocking challenges but emphasizes resilience and growth

Ashland Global Hlds faced challenges from customer destocking, leading to a decline in sales and adjusted EBITDA, but demonstrated resilience and strength in managing mix improvements and margins.
The company remains focused on innovation, growth opportunities, and market confidence, with investments in core assets and new technologies continuing despite market challenges.
Opportunities lie in new product initiatives, global expansion, and capacity additions in key technologies, positioning Ashland Global Hlds for future growth and success.
Despite short-term challenges, Ashland Global Hlds maintains a strategic outlook, emphasizing long-term strategies, market confidence, and a commitment to driving growth through innovation.

Ashland Global Hlds faces challenges but targets growth opportunities

Ashland Global Hlds faced challenges in Q4 and anticipates uncertainties in 2024 but remains focused on long-term growth opportunities.
The company is optimizing its portfolio, targeting new growth drivers, and managing costs effectively to navigate current market conditions.
Despite near-term challenges, Ashland is resilient and committed to maximizing upside potential while minimizing downside risks.
Management's emphasis on proactive inventory control, cost management, and strategic priorities underscores their commitment to long-term success.

Ashland Global Hlds reports mixed Q1 results, focuses on long-term growth

Ashland Global Hlds reported mixed Q1 results with sales decline and EBITDA decrease, focusing on long-term growth strategies and shareholder value creation.
Challenges include lower demand in key units, compensation adjustments, market dynamics, and cost management considerations, while opportunities lie in M&A, innovation, and market expansion.
Stability in certain business segments and strategic initiatives to optimize operations provide a foundation for future growth and profitability amidst current challenges.
Overall, Ashland's performance reflects a balancing act between short-term setbacks and long-term strategic positioning for sustainable growth and market competitiveness.

Ashland Global Hlds beats Q2 expectations, eyes growth opportunities

Ashland Global Hlds demonstrated resilience in Q2 2024, exceeding EBITDA outlook and focusing on strategic growth.
Despite challenges in pricing and market dynamics, the company maintains a strong financial position and growth focus.
Opportunities lie in innovation, segment growth, and EBITDA normalization above 2021 levels.
The company's performance reflects a balance of challenges, strengths, and a proactive approach to future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Ashland, Inc. engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.

Ashland Inc. has seen a softer start to 2023. The company's performance has been rather stable in the first half of the year, while growth was anticipated. Investors have priced in these setbacks, with valuations coming down amidst lower expectations.

Ashland Stock: A Tougher 2023

Investors need to pay close attention to Ashland (ASH) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Ashland (ASH) Stock?

Ashland (ASH) reported earnings 30 days ago. What's next for the stock?

Why Is Ashland (ASH) Down 6% Since Last Earnings Report?

Caterpillar

Target

Donaldson

Flowers Foods

Lennox International

Lowe's

LyondellBasell Industries

Medtronic

Monro

Northrop Grumman

Insperity

TowneBank

Union Pacific

The latter half of May was disappointing for dividend growth investors, as Lowe's pulled back on its dividend growth rate and Union Pacific skipped its annual increase. The big increases came from smaller companies. The only double-digit boost came from chemical company Ashland, while staffing firm Insperity and regional bank TowneBank announced 9% boosts. The announcements of dividend increases will slow down as summer approaches, but we should still see double-digit boosts from Kroger, UnitedHealth and Great Southern Bancorp.

Caterpillar, Target Among 10 Companies To Announce Annual Dividend Increases In June

Sales are stabilizing after a long restructuring process, but demand remains weak as customers hold high inventories. Profit margins have increased significantly in recent years thanks to the divestment of less profitable businesses.

Ashland: Strong Performance Despite Macroeconomic Headwinds

Expeditors International of Washington

FactSet Research Systems

First Merchants

Hamilton Beach Brands Hld

Houlihan Lokey

ManpowerGroup

Materion

NACCO Industries

PepsiCo

QUALCOMM

Schwab US Dividend Equity ETF

Advanced Drainage Systems

Watts Water Technologies

All these stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 8.2% and a median increase of 6.3%.

15 Upcoming Dividend Increases, Including 1 Dividend King

Ashland's (ASH) goal is to have an annual dividend payout ratio of about 30% of adjusted income from continuing operations.

Ashland (ASH) Raises Dividend, Announces Share Buyback Plan

Apple

Arbor Realty Trust

Archer-Daniels-Midland Company

Aflac

Assured Guaranty

Apartment Income REIT Corp

Amgen

Ameriprise Financial

Artesian Resources

Atmos Energy

Atlantic Union Bankshares Corp

Armstrong World Industries

American States Water

Black Hills

Brown & Brown

BWX Technologies

Cardinal Health

Cabot

Cogent Communications Holdings

Cognex

Cummins

Costco

Carlisle Companies

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.

Dividend Champion, Contender, And Challenger Highlights: Week Of May 14

WILMINGTON, Del., May 11, 2023 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.385 cents per share on the company's common stock representing a 15 percent increase from the previous quarter. The dividend is payable on June 15, 2023, to stockholders of record at the close of business on June 1, 2023. As of April 30, 2023, there were 52,353,681 shares of Ashland common stock outstanding.

Ashland announces 15 percent increase in quarterly dividend, new dividend policy and $100 million share repurchase program

Ingevity

Mativ Inc

Ashland and Ingevity both came up short of analysts' expectations regarding quarterly earnings reports. Management teams for Ashland and Ingevity both see a less auspicious 2023.

Why Shares of Ashland, Ingevity, and Mativ Are Falling This Week

Demand weakness in personal care and specialty additives and customer inventory destocking hurt Ashland's (ASH) Q2 results.

Ashland's (ASH) Earnings and Revenues Lag Estimates in Q2

Ashland Inc. (NYSE:ASH ) Q2 2023 Earnings Conference Call May 3, 2023 9:00 AM ET Company Participants Seth Mrozek - Director, Investor Relations Guillermo Novo - Chair & Chief Executive Officer Kevin Willis - Senior Vice President & Chief Financial Officer Conference Call Participants Christopher Parkinson - Mizuho Securities Lucas Beaumont - UBS Michael Sison - Wells Fargo John McNulty - BMO Mike Harrison - Seaport Research Partners David Begleiter - Deutsche Bank John Roberts - Credit Suisse Laurence Alexander - Jefferies Jeffrey Zekauskas - JPMorgan Operator Good day, and thank you for standing by. Welcome to the Ashland Second Quarter 2023 Earnings Call.

Ashland Inc. (ASH) Q2 2023 Earnings Call Transcript

Ashland (ASH) came out with quarterly earnings of $1.43 per share, missing the Zacks Consensus Estimate of $1.53 per share. This compares to earnings of $1.50 per share a year ago.

Ashland (ASH) Misses Q2 Earnings and Revenue Estimates

WILMINGTON, Del., May 02, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the second quarter of fiscal year 2023, which ended March 31, 2023. The global additives and specialty ingredients company holds leadership positions in high-quality, consumer-focused markets including pharmaceuticals, personal care and architectural coatings.

Ashland reports financial results1 for second quarter of fiscal year 2023 and updates fiscal year 2023 financial outlook; announces completion of $200 million share repurchase

WILMINGTON, Del., May 01, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced James Minicucci will join Ashland's executive team as senior vice president strategy, mergers and acquisitions, and portfolio management, reporting to Guillermo Novo, chair and chief executive officer, Ashland.

Ashland adds James Minicucci as new leader of strategy, mergers and acquisitions and portfolio management

Wilmington, Del., April 21, 2023 (GLOBE NEWSWIRE) -- In celebration of Earth Day 2023, Ashland Inc. (NYSE: ASH) announced the company's continued support of The Nature Conservancy (TNC) Plant A Billion Trees forest restoration project and TNC's youth engagement Nature Lab with a total donation of $50,000.

Celebrating Earth Day, Ashland continues support of The Nature Conservancy Plant A Billion Trees forest restoration effort and Nature Lab youth curriculum

WILMINGTON, Del., April 20, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its second-quarter earnings release at approximately 5 p.m. ET on Tuesday, May 2, 2023. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Wednesday, May 3, 2023. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com .

Ashland sets date for fiscal 2023 second-quarter earnings release and conference call webcast

Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ashland (ASH) Earnings Expected to Grow: What to Know Ahead of Q2 Release

Avient Corp

Avery Dennison

Corteva Inc

New Linde PLC

Martin Marietta Materials

MP Materials

Owens-Illinois

Vulcan Materials

The short-term outlook for materials stocks is low, but these nine names could be diamonds in the rough.

The 9 Best Materials Stocks to Buy Now

Ashland (ASH) gains on strong demand in its consumer end markets and its pricing actions to counter inflation.

Why You Should Add Ashland (ASH) Stock to Your Portfolio

Ashland (ASH) benefits from healthy demand in most consumer end markets, the Schulke & Mayr acquisition and its pricing and mix improvement actions to counter inflation.

Here's Why You Should Retain Ashland (ASH) Stock for Now

Ashland (ASH) benefits from strength in its global pharma business, the Schulke & Mayr acquisition and its pricing and mix improvement actions to counter inflation.

News for Ashland Global Hlds Stock (ASH)